Cost-effectiveness of B-Type Natriuretic Peptide Testing in Patients With Acute Dyspnea
Authors:
- Christian MuellerCMChristian Mueller
- Kirsten Laule-KilianKLKirsten Laule-Kilian
- Christian SchindlerCSChristian Schindler
- Theresia KlimaTKTheresia Klima
- Barbara FranaBFBarbara Frana
- Daniel RodriguezDRDaniel Rodriguez
- André ScholerASAndré Scholer
- Michael ChristMCMichael Christ
- André P. PerruchoudAPAndré P. Perruchoud
Open Access
- 22 May 2006
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 166 (10) , 1081-1087
Abstract
The clinical diagnosis of heart failure (HF) may be difficult,1-4 particularly in patients presenting with acute dyspnea in the emergency department (ED). Clinical history, physical examination, electrocardiography, and chest radiography may provide valuable clues as to whether HF is the cause of acute dyspnea.1,2 However, after review of this information, physicians are left with considerable diagnostic uncertainty in up to 50% of patients.4-6 Misdiagnosis of HF can lead to morbidity and increased resource utilization.Keywords
This publication has 24 references indexed in Scilit:
- Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute DyspneaNew England Journal of Medicine, 2004
- B‐Type Natriuretic Peptide: The Level and the Drug—Partners in the Diagnosis and Management of Congestive Heart FailureCongestive Heart Failure, 2004
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureNew England Journal of Medicine, 2002
- ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure)Circulation, 2001
- Guidelines for the diagnosis and treatment of chronic heart failureEuropean Heart Journal, 2001
- Biochemical detection of left-ventricular systolic dysfunctionThe Lancet, 1998
- Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimationHealth Economics, 1997
- Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.Circulation, 1994
- Plasma brain natriuretic peptide in assessment of acute dyspnoeaThe Lancet, 1994
- Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.Journal of Clinical Investigation, 1991